Xbiotech

^{Priced, Nasdaq: XBIT}

Developing antibodies for colorectal cancer and various other conditions.

Industry: Other

First Day Return: +22.4%

XBIT

Developing antibodies for colorectal cancer and various other conditions.

IPO News for Xbiotech

US IPO Weekly Recap: 7 IPOs see Etsy vault 70%, proving vintage is in vogue 04/17/15
Colorectal cancer biotech Xbiotech prices $76 million IPO at $19 midpoint 04/15/15
Week ahead: Crafts, cancer cures and cash flow in a week with 7 IPOs including Party City 04/13/15

IPO Data
IPO Date	04/14/2015
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$76
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.xbiotech.com
Headquarters	Austin, TX, United States
Founded	2005
Employees at IPO	56

IPO News for Xbiotech

Xbiotech (XBIT) Performance